1/99
Comprehensive practice flashcards covering the individual metabolism of amino acids, including catecholamine and thyroid hormone synthesis, inborn errors of metabolism (PKU, alkaptonuria, tyrosinemia, homocystinuria, MSUD, organic acidemias), sulfur amino acid cycles, and neurotransmitter pathways.
Phenylalanine
A nutritionally essential, glucogenic and ketogenic aromatic amino acid that is normally converted into tyrosine; less than 50% of dietary intake is used for protein synthesis in children.
Tyrosine
A non-essential glucogenic and ketogenic amino acid formed from phenylalanine; it spares dietary phenylalanine intake and becomes nutritionally essential in patients with phenylketonuria.
Phenylalanine hydroxylase (PAH)
A hepatic monooxygenase enzyme that catalyzes the irreversible conversion of phenylalanine to tyrosine using molecular oxygen (O2) and tetrahydrobiopterin (BH4).
Tetrahydrobiopterin (BH4)
An essential cofactor required by hydroxylases of phenylalanine, tyrosine, and tryptophan, as well as nitric oxide synthase, which is oxidized to dihydrobiopterin during hydroxylation.
Dihydropteridine reductase
The enzyme responsible for regenerating active tetrahydrobiopterin (BH4) from dihydrobiopterin (BH2) using NADPH+H+.
Classical PKU (Type I)
An autosomal recessive inborn error of metabolism caused by mutations in the PAH gene on chromosome 12q, leading to impaired conversion of phenylalanine to tyrosine.
Malignant PKU (Type II)
A severe variant of hyperphenylalaninemia caused by deficiency of tetrahydrobiopterin (BH4) or dihydropteridine reductase, leading to secondary deficits in dopamine, epinephrine, norepinephrine, and serotonin.
Phenylketones
Alternative toxic transamination metabolites of phenylalanine—specifically phenylpyruvate, phenylacetate, and phenyllactate—that accumulate and are excreted in the urine in PKU.
Musty (mousy) odor of PKU
The characteristic odor of skin and urine in phenylketonuria caused by elevated urinary excretion of phenylpyruvic acid and phenylacetate.
Oral BH4 loading test
A diagnostic procedure used to distinguish classic PKU from BH4 deficiency: serum phenylalanine levels decrease significantly in BH4 deficiency but remain elevated in PAH deficiency.
Aspartame
An artificial dipeptide sweetener that hydrolyzes to release phenylalanine and must be strictly avoided by individuals with phenylketonuria.
Maternal PKU syndrome
A teratogenic syndrome resulting from elevated maternal blood phenylalanine during pregnancy, presenting in offspring as microcephaly, congenital heart defects, and severe mental retardation.

Catecholamine-O-methyltransferase (COMT)
A SAM-dependent enzyme that inactivates catecholamines by transferring a methyl group to one of their phenolic hydroxyl groups.
Monoamine oxidase (MAO)
A mitochondrial outer-membrane enzyme that catalyzes oxidative deamination of catecholamines and serotonin to their corresponding aldehydes.
Vanillylmandelic acid (VMA)
The primary urinary end-metabolite of epinephrine and norepinephrine catabolism; measured in 24-hour urine for diagnosing pheochromocytoma and neuroblastoma.
Homovanillic acid (HVA)
The terminal degradation product of dopamine metabolism produced by the combined actions of MAO and COMT; utilized in the diagnostics of schizophrenia and Parkinson disease.
Pheochromocytoma
A catecholamine-secreting tumor of the adrenal medulla causing severe hypertension, episodic headaches, diaphoresis, and tachycardia, diagnosed via elevated 24-hour urinary VMA.
Parkinson's disease
A neurodegenerative disorder caused by degeneration of dopaminergic neurons in the substantia nigra, leading to dopamine depletion, spasticity, resting tremors, and postural instability.
L-DOPA
The metabolic precursor of dopamine that crosses the blood-brain barrier to restore central dopamine levels in the treatment of Parkinson's disease.
Thyroglobulin
A large thyroid follicular glycoprotein that serves as the matrix whose tyrosine residues undergo iodination and coupling to synthesize thyroid hormones.
Monoiodotyrosine (MIT)
A tyrosyl residue within thyroglobulin that has been iodinated with a single iodine atom (I2).
Diiodotyrosine (DIT)
A tyrosyl residue within thyroglobulin iodinated with two iodine atoms (I2); couplings of DIT yield active thyroid hormones.
Thyroxine (T4)
The major circulating thyroid hormone formed inside thyroglobulin by the oxidative condensation of two diiodotyrosine (DIT) residues.
Triiodothyronine (T3)
The biologically active thyroid hormone formed by the coupling of one monoiodotyrosine (MIT) residue and one diiodotyrosine (DIT) residue.
Alkaptonuria
An autosomal recessive congenital disorder of tyrosine catabolism caused by mutations in the HGD gene, leading to accumulation of homogentisic acid.
Homogentisic acid dioxygenase
The deficient liver enzyme in alkaptonuria that normally converts homogentisate into maleylacetoacetate.
Ochronosis
A bluish-black pigmentation of connective tissues, cartilage, tendons, and sclera caused by the tissue deposition and oxidation of homogentisic acid in alkaptonuria.

Darkening of urine on standing
A diagnostic hallmark of alkaptonuria in which urine turns brownish-black after prolonged air exposure or alkalinization due to homogentisic acid oxidation.

Nitisinone
An inhibitor of 4-hydroxyphenylpyruvate dioxygenase used in alkaptonuria and tyrosinemia type I to prevent the upstream synthesis and accumulation of toxic homogentisic acid.
Tyrosinemia Type I
An autosomal recessive disorder caused by deficiency of fumarylacetoacetate hydrolase, causing severe liver and kidney failure, rickets, and a cabbage-like body odor.
Fumarylacetoacetate hydrolase
The terminal enzyme of tyrosine degradation that cleaves fumarylacetoacetate into fumarate and acetoacetate; deficient in tyrosinemia type I.
Succinylacetone
A toxic byproduct formed from accumulated fumarylacetoacetate and maleylacetoacetate that is pathognomonic for tyrosinemia type I.
Cabbage-like odor
The distinctive body odor found in infants with tyrosinemia type I caused by the accumulation of tyrosine degradation byproducts.
Tyrosinemia Type II (Richner-Hanhart syndrome)
An autosomal recessive inborn error of tyrosine catabolism caused by deficient activity of tyrosine aminotransferase (TAT), causing corneal ulcers and hyperkeratosis.
Tyrosine aminotransferase (TAT)
A transaminase that converts tyrosine to 4-hydroxyphenylpyruvate; its genetic deficiency leads to plasma tyrosine elevation in tyrosinemia type II.
Palmoplantar hyperkeratosis
Painful, circumscribed callused skin lesions on the weight-bearing areas of the palms and soles characteristically seen in tyrosinemia type II.

Tyrosinase
A copper-containing enzyme in melanocytes that oxidizes tyrosine to L-DOPA and subsequently to DOPAquinone in melanin synthesis.
Eumelanin
A brown-to-black insoluble pigment produced from DOPAquinone via DOPAchrome, responsible for dark skin and hair pigmentation.
Pheomelanin
A yellow-to-red sulfur-containing pigment synthesized when DOPAquinone conjugates with cysteine or glutathione.
Oculocutaneous albinism Type 1
An autosomal recessive condition caused by tyrosinase deficiency, characterized by milky white skin, white hair, pink/translucent irides, photophobia, and nystagmus.

Histidine
A polar, basic, nutritionally essential glucogenic amino acid whose imidazole ring possesses a pKa≈6, providing maximum physiological buffering capacity.
Carnosine and anserine
Histidine-derived dipeptides synthesized in skeletal muscle that function to buffer intracellular pH during anaerobic contraction.
Histamine
A vasoactive amine synthesized by the decarboxylation of histidine; stored predominantly within tissue mast cells and circulating basophils.
Histidine decarboxylase
A pyridoxal phosphate (PLP, vitamin B6)-dependent enzyme that decarboxylates histidine to yield histamine.
Histidinemia
A mostly benign autosomal recessive disorder characterized by impaired histidine degradation and elevated histidine in blood and urine due to histidase deficiency.
Histidase
The initial enzyme of histidine catabolism that deaminates histidine to urocanate; deficient in histidinemia.
Methionine
An essential, glucogenic sulfur-containing amino acid that serves as the initiator residue in eukaryotic translation and precursor of SAM and homocysteine.
S-Adenosylmethionine (SAM)
The 'active' high-energy sulfonium form of methionine produced with ATP; serves as the principal biological methyl group donor in transmethylation reactions.
S-Adenosylhomocysteine (SAH)
The demethylated product of SAM that is subsequently cleaved into adenosine and free homocysteine.
Homocysteine
A sulfur-containing non-proteinogenic amino acid intermediate derived from methionine demethylation; lies at the branch point of remethylation and transsulfuration.
Methionine synthase
A vitamin B12-dependent enzyme that remethylates homocysteine to methionine using N5-methyltetrahydrofolate (N5-CH3-FH4).
Betaine-homocysteine S-methyltransferase (BHMT)
A liver-specific enzyme that provides an alternative folate-independent remethylation pathway, converting homocysteine to methionine using betaine.
MTHFR gene polymorphism
A common genetic variation (up to 30% of the population) that produces a thermolabile methylenetetrahydrofolate reductase, impairing 5-MTHF synthesis and causing hyperhomocysteinemia.
Cystathionine β-synthase (CBS)
A vitamin B6-dependent transsulfuration enzyme that condenses homocysteine and serine into cystathionine; its deficiency causes classic homocystinuria.
Cystathionase (CSE)
A vitamin B6-dependent enzyme that cleaves cystathionine into cysteine and α-ketobutyrate, completing the transsulfuration pathway.
Homocysteine vascular toxicity
Vascular endothelial injury, oxidative stress, and platelet activation caused by elevated homocysteine, predisposing individuals to premature atherosclerosis and stroke.
Homocystinuria
An autosomal recessive inborn error of homocysteine catabolism presenting with intellectual disability, ectopia lentis, skeletal deformities, and severe thromboembolism.
Marfanoid habitus
A tall, slender body morphology with elongated limbs, arachnodactyly, kyphosis, and pectus deformities characteristic of patients with homocystinuria.

Ectopia lentis in homocystinuria
Subluxation of the ocular lens in a downward and inward ('down and in') direction, typically appearing after age 3.

Sodium nitroprusside test
A colorimetric urine screening test that turns an intense red color in the presence of free sulfhydryl-containing compounds such as homocysteine.
Cysteine
A polar, neutral, glucogenic amino acid containing a sulfhydryl (-SH) group, synthesized from methionine; becomes essential in homocystinuria.
N-acetylcysteine (NAC)
A cysteine derivative that enhances intracellular glutathione (GSH) synthesis, chelates heavy metals, and serves as an antidote for acetaminophen poisoning.
Glutathione (GSH)
A protective intracellular tripeptide (glutamate-cysteine-glycine) that acts as an antioxidant by reducing toxic hydrogen peroxide (H2O2) in erythrocytes.
Cystine
A dimer composed of two cysteine molecules joined by a covalent disulfide bond; poorly soluble at acidic urine pH.
Cystinuria
An inherited defect in renal and intestinal reabsorption of the dibasic amino acids (COLA: cystine, ornithine, lysine, arginine), precipitating cystine kidney stones.
Glutaric acidemia type I
An autosomal recessive inborn error caused by glutaryl-CoA dehydrogenase deficiency, impairing lysine and tryptophan catabolism and causing infantile macrocephaly.
Taurine
A specialized sulfonic acid derivative of cysteine conjugated to bile acids in the liver to enhance their intestinal solubility and emulsification.
Selenocysteine
A non-standard amino acid structurally identical to cysteine with selenium replacing sulfur, located in the active site of glutathione peroxidase.
Tryptophan
An essential, hydrophobic, glucogenic and ketogenic aromatic amino acid that acts as a precursor for serotonin, melatonin, and niacin.
Sparing effect of tryptophan on niacin
The metabolic relationship wherein 60mg of dietary tryptophan is converted into 1mg of niacin (vitamin B3).
Pellagra
A systemic nutritional deficiency disease resulting from combined deficiency of niacin and tryptophan, characterized by diarrhea, dermatitis, dementia, and death.
Kynureninase
A pyridoxal phosphate (PLP, vitamin B6)-dependent enzyme in the tryptophan catabolic cascade toward NAD/NADP synthesis.
Isoniazid (INH)
An antitubercular antibiotic that competitively inhibits pyridoxine (B6) and kynureninase, causing peripheral neuropathy unless pyridoxine is co-administered.
Serotonin (5-HT)
A biogenic amine neurotransmitter and vasoconstrictor synthesized from tryptophan in the gut mucosa, brain, and platelets via tryptophan hydroxylase.
5-Hydroxyindoleacetic acid (5-HIAA)
The major end-product of serotonin degradation by monoamine oxidase A (MAO-A), excreted in the urine and elevated in carcinoid syndrome.
Carcinoid syndrome
A neuroendocrine tumor of serotonin-secreting APUD cells in the gastrointestinal tract presenting with cutaneous flushing, diarrhea, bronchospasm, and high urinary 5-HIAA.
Melatonin
A sleep-inducing pineal hormone synthesized from serotonin via acetylation and SAM-dependent methylation that controls circadian rhythms and scavenges free radicals.
Cheese reaction
A life-threatening hypertensive crisis occurring when patients taking MAO inhibitors ingest aged cheeses or red wine containing unmetabolized tyramine.
Arginine
A basic, semi-essential amino acid required during periods of rapid growth that serves as a precursor for urea, creatine, polyamines, and nitric oxide.
Arginine:glycine amidinotransferase
The renal enzyme that catalyzes the initial committal step of creatine synthesis, transferring an amidino group from arginine to glycine to yield guanidinoacetate.
Guanidinoacetate N-methyltransferase
The hepatic enzyme that methylates guanidinoacetate using SAM to form creatine, which is then released into circulation.
Creatine phosphate
A high-energy phosphagen reservoir in skeletal muscle and brain that rapidly donates a high-energy phosphate to ADP to regenerate ATP during short bursts of exertion.
Creatine kinase
The reversible enzyme that phosphorylates creatine to creatine phosphate in resting muscle and regenerates ATP from ADP during active muscle contraction.
Creatinine
The spontaneous non-enzymatic cyclization waste product of creatine phosphate, produced at a constant rate proportional to muscle mass and cleared by glomerular filtration.
Nitric oxide synthase (NOS)
A cytosolic enzyme that oxidizes L-arginine to L-citrulline and nitric oxide (NO) utilizing NADPH, FAD, FMN, heme, and tetrahydrobiopterin (BH4).
Endothelial NOS (eNOS)
The constitutive, calcium/calmodulin-dependent isoform of nitric oxide synthase that generates NO to maintain vascular tone and promote vasodilation.
Inducible NOS (iNOS)
The calcium-independent nitric oxide synthase isoform induced by inflammatory cytokines in macrophages to synthesize large cytotoxic amounts of NO.
Vasodilation mechanism of Nitric Oxide
Endothelial NO diffuses into vascular smooth muscle, activating soluble guanylyl cyclase to form cGMP, which stimulates protein kinase G to elicit muscle relaxation.
Alanine aminotransferase (ALT)
A pyridoxal phosphate (PLP)-dependent enzyme that reversibly transfers an amino group from alanine to α-ketoglutarate, producing pyruvate and glutamate.
Glutamate dehydrogenase
A mitochondrial enzyme that catalyzes the reversible oxidative deamination of glutamate to α-ketoglutarate and free ammonia, using NAD+ or NADP+.
Glutamine synthetase
An ATP-dependent enzyme in the brain and perivenous hepatocytes that detoxifies circulating ammonia by conjugating it with glutamate to form non-toxic glutamine.
Glutaminase
An enzyme concentrated in renal tubular cells that deamidates glutamine to glutamate and free ammonium (NH4+), aiding in systemic acid-base regulation.
Gamma-aminobutyric acid (GABA)
The principal inhibitory neurotransmitter of the central nervous system, synthesized via decarboxylation of L-glutamate.
Glutamate decarboxylase
A pyridoxal phosphate (PLP, vitamin B6)-dependent enzyme that catalyzes the synthesis of GABA from glutamic acid.
Asparaginase
An antineoplastic enzyme that hydrolyzes serum asparagine to aspartate and ammonia, starving leukemic cells that cannot synthesize their own asparagine.
Maple syrup urine disease (MSUD)
An autosomal recessive disorder caused by deficiency of branched-chain α-keto acid dehydrogenase, presenting with sweet-smelling urine and severe neonatal dystonia/opisthotonos.

Branched-chain alpha-keto acid dehydrogenase (BCKDH)
A thiamine pyrophosphate (TPP)-dependent multienzyme mitochondrial complex that degrades transaminated keto acids of leucine, isoleucine, and valine.
Propionic acidemia
An autosomal recessive organic acidemia caused by propionyl-CoA carboxylase (biotin-dependent) deficiency, characterized by elevated propionic acid and ketoacidosis.
Methylmalonic acidemia (MMA)
An autosomal recessive metabolic defect caused by deficiency of the vitamin B12-dependent enzyme methylmalonyl-CoA mutase, causing methylmalonic acid accumulation.
Isovaleric acidemia (IVA)
An autosomal recessive organic acidemia caused by isovaleryl-CoA dehydrogenase deficiency in leucine catabolism, characteristically producing a distinctive 'sweaty-feet' body odor.